These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 37450079)

  • 21. N6-methyladenosine RNA modification and its interaction with regulatory non-coding RNAs in colorectal cancer.
    Ge Y; Liu T; Wang C; Zhang Y; Xu S; Ren Y; Feng Y; Yin L; Pu Y; Liang G
    RNA Biol; 2021 Nov; 18(sup2):551-561. PubMed ID: 34674600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Publisher Correction: N6-methyladenosine-modified ALDH9A1 modulates lipid accumulation and tumor progression in clear cell renal cell carcinoma through the NPM1/IQGAP2/AKT signaling pathway.
    Tan D; Miao D; Zhao C; Shi J; Lv Q; Lu F; Ruan H; Xiong Z; Zhang X
    Cell Death Dis; 2024 Aug; 15(8):635. PubMed ID: 39209846
    [No Abstract]   [Full Text] [Related]  

  • 23. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functions of N6-methyladenosine in cancer metabolism: from mechanism to targeted therapy.
    He J; Liu F; Zhang Z
    Biomark Res; 2023 Apr; 11(1):40. PubMed ID: 37055798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N6-methyladenosine (m6A) modification in gynecological malignancies.
    Zhang C; Liu N
    J Cell Physiol; 2022 Sep; 237(9):3465-3479. PubMed ID: 35802474
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methyltransferase-like 3 Modulates Severe Acute Respiratory Syndrome Coronavirus-2 RNA N6-Methyladenosine Modification and Replication.
    Zhang X; Hao H; Ma L; Zhang Y; Hu X; Chen Z; Liu D; Yuan J; Hu Z; Guan W
    mBio; 2021 Aug; 12(4):e0106721. PubMed ID: 34225491
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of circular RNAs and N6-methyladenosine (m6A) modification on cancer biology.
    Zhang G; Hou J; Mei C; Wang X; Wang Y; Wang K
    Biomed Pharmacother; 2023 Mar; 159():114260. PubMed ID: 36657303
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The emerging roles and mechanism of N6-methyladenosine (m
    Zhu W; Zhao R; Guan X; Wang X
    Front Pharmacol; 2023; 14():1192495. PubMed ID: 37284313
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N6-Methyladenosine-Sculpted Regulatory Landscape of Noncoding RNA.
    Zhang Z; Wei W; Wang H; Dong J
    Front Oncol; 2021; 11():743990. PubMed ID: 34722298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology.
    Chen J; Tian Y; Zhang Q; Ren D; Zhang Q; Yan X; Wang L; He Z; Zhang W; Zhang T; Yuan X
    Stem Cells Dev; 2021 Jan; 30(1):17-28. PubMed ID: 33231507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Methyladenosine Modification in RNAs: From Regulatory Roles to Therapeutic Implications in Cancer.
    Qu X; Zhang Y; Sang X; Ren D; Zhao H; Wong STC
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804965
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Relationship Between the Network of Non-coding RNAs-Molecular Targets and N6-Methyladenosine Modification in Colorectal Cancer.
    Lu S; Ding X; Wang Y; Hu X; Sun T; Wei M; Wang X; Wu H
    Front Cell Dev Biol; 2021; 9():772542. PubMed ID: 34938735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. N6-methyladenosine functions and its role in skin cancer.
    Ran Y; Yan Z; Jiang B; Liang P
    Exp Dermatol; 2023 Jan; 32(1):4-12. PubMed ID: 36314059
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The emerging roles of N6-methyladenosine RNA methylation in human cancers.
    Shen H; Lan Y; Zhao Y; Shi Y; Jin J; Xie W
    Biomark Res; 2020; 8():24. PubMed ID: 32612834
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications.
    Luo J; Xu T; Sun K
    Front Cell Dev Biol; 2021; 9():670711. PubMed ID: 34150765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Progression of N6-methyladenosine Study and Its Role in Neuropsychiatric Disorders.
    Lei C; Wang Q
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N6-methyladenine RNA modification and cancer.
    Yang J; Chen J; Fei X; Wang X; Wang K
    Oncol Lett; 2020 Aug; 20(2):1504-1512. PubMed ID: 32724392
    [TBL] [Abstract][Full Text] [Related]  

  • 39. N6-Methyladenosine Modification Opens a New Chapter in Circular RNA Biology.
    Wu J; Guo X; Wen Y; Huang S; Yuan X; Tang L; Sun H
    Front Cell Dev Biol; 2021; 9():709299. PubMed ID: 34368159
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.